INSIGHTS ON DRUG DEVELOPMENT
-
Overcoming Volume And Viscosity Barriers In Biologic Formulations
Learn how advanced containment solutions support high-viscosity biologics, improve device compatibility, enhance injection performance, and address evolving drug delivery and patient care challenges.
-
Comprehensive GMP Testing Services
Eurofins delivers global GMP testing with 45+ facilities, ensuring regulatory acceptance, quality, and trusted service from starting materials to finished products.
-
Spray Dried Biologics For Injectable Dosage Forms
Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.
-
NGS Identification Of Internal Tandem Duplications In FLT3
Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.
-
Solving Bioavailability Challenges In bRo5 Drugs3/20/2026
Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.
-
How The Accelerator™ Drug Development Model Enhances eNPV2/25/2026
Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.
-
Lonza Advanced Synthesis Capabilities Update February 2026: AI Drug Development3/2/2026
Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.
-
How Biocatalysts Address Process Development Issues7/23/2026
Antje Gupta, General Manager of Cambrex IEP in Wiesbaden, on where biocatalysis outperforms conventional chemistry — matching enzyme classes to target conversions and production volumes to find the more scalable, more economical route.
-
Aggregate Analysis Of Tirzepatide12/11/2025
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
DRUG DEVELOPMENT SOLUTIONS
-
High-intensity sweeteners can improve palatability across oral dosage forms. Learn more about taste-masking performance, sweetness potency, and solubility to make a more informed excipient selection.
-
Gain human-relevant insights with patient-derived assay-ready organoids.
-
Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
Leica S9 I Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica